Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer's Betaferon Approved In China; Launch Likely In Mid 2010

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - Germany-based Bayer Schering Pharma announced Dec. 1 that China's State FDA approved its multiple sclerosis treatment Betaferon/Betaseron (interferon beta-1b). Bayer plans to launch the drug by mid-2010
Advertisement

Related Content

Bayer’s Asia Pacific Regional Head Chris Lee On Bayer’s New Global R&D Center In Beijing And China’s Rising 21st Century Importance: An Interview With PharmAsia News
Advertisement
UsernamePublicRestriction

Register

SC070712

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel